94 related articles for article (PubMed ID: 19739270)
1. Pattern of use of adjuvant chemotherapy for stage II colon cancer: a single-institution experience.
Osarogiagbon RU; Sachdev JC; Khattak AG; Kronish LE
Clin Colorectal Cancer; 2009 Apr; 8(2):94-9. PubMed ID: 19739270
[TBL] [Abstract][Full Text] [Related]
2. Pattern of Use of Adjuvant Chemotherapy for Stage II Colon Cancer: A Single-Institution Experience.
Osarogiagbon RU; Sachdev JC; Khattak AG; Kronish LE
Clin Colorectal Cancer; 2009 Mar; 8(2):94-9. PubMed ID: 19423502
[TBL] [Abstract][Full Text] [Related]
3. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
[TBL] [Abstract][Full Text] [Related]
4. Patterns of adjuvant chemotherapy for stage II and III colon cancer in France and Italy.
Bouvier AM; Minicozzi P; Grosclaude P; Bouvier V; Faivre J; Sant M
Dig Liver Dis; 2013 Aug; 45(8):687-91. PubMed ID: 23428703
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
[TBL] [Abstract][Full Text] [Related]
6. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
Babcock BD; Aljehani MA; Jabo B; Choi AH; Morgan JW; Selleck MJ; Luca F; Raskin E; Reeves ME; Garberoglio CA; Lum SS; Senthil M
Ann Surg Oncol; 2018 Jul; 25(7):1980-1985. PubMed ID: 29675762
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline.
Jonker DJ; Spithoff K; Maroun J;
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):314-22. PubMed ID: 21397476
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.
Cakar B; Varol U; Junushova B; Muslu U; Gursoy Oner P; Gokhan Surmeli Z; Cirak Y; Karaca B; Sezgin C; Karabulut B; Uslu R
J BUON; 2013; 18(2):372-6. PubMed ID: 23818348
[TBL] [Abstract][Full Text] [Related]
9. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.
Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J
ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835
[TBL] [Abstract][Full Text] [Related]
10. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
Benson AB; Schrag D; Somerfield MR; Cohen AM; Figueredo AT; Flynn PJ; Krzyzanowska MK; Maroun J; McAllister P; Van Cutsem E; Brouwers M; Charette M; Haller DG
J Clin Oncol; 2004 Aug; 22(16):3408-19. PubMed ID: 15199089
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.
van Gils CW; Koopman M; Mol L; Redekop WK; Uyl-de Groot CA; Punt CJ
Acta Oncol; 2012 Jan; 51(1):57-64. PubMed ID: 22122695
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy decision-making in stage II colon adenocarcinoma associated with patients' age and high-risk factors.
Zheng P; Ye C; Liu H; Gao X; Huang H
Int J Colorectal Dis; 2023 Dec; 39(1):3. PubMed ID: 38091096
[TBL] [Abstract][Full Text] [Related]
13. Why adjuvant chemotherapy for stage III colon cancer was not given: Reasons for non-recommendation by clinicians or patient refusal.
Gilbar P; Lee A; Pokharel K
J Oncol Pharm Pract; 2017 Mar; 23(2):128-134. PubMed ID: 26692241
[TBL] [Abstract][Full Text] [Related]
14. Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces.
Wirtzfeld DA; Mikula L; Gryfe R; Ravani P; Dicks EL; Parfrey P; Gallinger S; Pollett WG
Can J Surg; 2009 Apr; 52(2):92-7. PubMed ID: 19399202
[TBL] [Abstract][Full Text] [Related]
15. Hospital Variability in Use of Adjuvant Chemotherapy for Patients with Stage 2 and 3 Colon Cancer.
Daly MC; Hanseman DJ; Abbott DE; Shah SA; Paquette IM
Dis Colon Rectum; 2016 Dec; 59(12):1134-1141. PubMed ID: 27824698
[TBL] [Abstract][Full Text] [Related]
16. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
[TBL] [Abstract][Full Text] [Related]
17. Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer.
Teufel A; Gerken M; Hartl J; Itzel T; Fichtner-Feigl S; Stroszczynski C; Schlitt HJ; Hofstädter F; Klinkhammer-Schalke M
BMC Cancer; 2015 May; 15():419. PubMed ID: 25985893
[TBL] [Abstract][Full Text] [Related]
18. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
[TBL] [Abstract][Full Text] [Related]
19. Omission of Adjuvant Chemotherapy Is Associated With Increased Mortality in Patients With T3N0 Colon Cancer With Inadequate Lymph Node Harvest.
Wells KO; Hawkins AT; Krishnamurthy DM; Dharmarajan S; Glasgow SC; Hunt SR; Mutch MG; Wise P; Silviera ML
Dis Colon Rectum; 2017 Jan; 60(1):15-21. PubMed ID: 27926553
[TBL] [Abstract][Full Text] [Related]
20. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
